MedPath

ORFENACE TABLET 100MG

ORFENACE TABLET 100MG

Dormant
DIN Number

02047535

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

Sterimax Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02047535
AIG Number0102078001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
M03BC01 ORPHENADRINE (CITRATE)
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification12:20.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ORPHENADRINE CITRATEActive
Strength: 100 MG
Monograph: ORPHENADRINE CITRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.